Exact Sciences Corporation's (NASDAQ:EXAS) Buy Rating Reaffirmed at Canaccord Genuity

Paterniano Del Favero
Luglio 28, 2017

This stock is ahead of its 52-week low with +0.33%. Analysts set a 12-month price target of $25.83 a share. Bank of America Corporation reiterated a "buy" rating on shares of Exact Sciences Corporation in a report on Wednesday. Currently Exact Sciences Corporation (EXAS) stock is moving with Upswing trend.

Shares of Exact Sciences Corporation (NASDAQ:EXAS) have climbed in the previous month. The firm earned "Buy" rating on Thursday, June 16 by Craig Hallum.

A number of equities analysts have recently weighed in on EXAS shares. It is meant to chart the current and historical strength or weakness of a stock or market based on the closing prices of a recent trading period. The rating was maintained by Roth Capital with "Buy" on Wednesday, May 4.

Exact Sciences Corporation (EXAS) stock's current distance from 20-Day Simple Moving Average is 0.18% and moving 6.38% away from 50-Day Simple Moving Average while traded up 58.77% from 200-Day Simple Moving Average. KeyBanc Capital Markets has "Overweight" rating and $43 target. Comparatively, EXAS posted earnings of $-0.37 per share in the same quarter, a year earlier.

Quarterly Revenue growth year over year is 226 Percent.

The company's Average Earnings Estimate for the Current Fiscal quarter is $-0.31, according to consensus of 15 analysts. (NYSE:HP) has been 2.25 million shares per day over the past 30 days. It also upped China Pete & Chem Cor (NYSE:SNP) stake by 37,217 shares and now owns 70,227 shares. Five research analysts have rated the stock with a hold rating and twelve have given a buy rating to the company. It was reported on Jul, 28 by Barchart.com. The firm has "Buy" rating by BTIG Research given on Monday, July 17. The stock has "Hold" rating by Benchmark on Tuesday, October 6. Stephens has "Equal Weight" rating and $97 target. The stock has "Overweight" rating by JP Morgan on Wednesday, August 31.

Exact Sciences Corporation (EXAS) has the market capitalization of $4.67 Billion.

Investors sentiment decreased to 1.08 in Q4 2016. A P/B ratio of less than 1.0 can indicate that a stock is undervalued, while a ratio of greater than 1.0 may indicate that a stock is overvalued. Moving averages are used as a strong indicator for technical stock analysis and it helps investors in figuring out where the stock has been and also facilitate in determining where it may be possibly heading. 31 funds opened positions while 67 raised stakes.

Exact Sciences Corporation (NASDAQ:EXAS) has seen its price went down by -7.35% over the course of one week. Ardsley Advisory Prns has 0.95% invested in EXACT Sciences Corporation (NASDAQ:EXAS) for 430,000 shares. Therefore, there is certainly still some pain for investors who want to avoid this falling stock. Now trading with a market value of 4.40B, the company has a mix of catalysts and obstacles that spring from the nature of its operations. Financial Architects Inc increased its stake in shares of Exact Sciences Corporation by 90.0% in the second quarter. State Street reported 0.01% in EXACT Sciences Corporation (NASDAQ:EXAS). A firm having high P/E ratio generally signified positive future performance and investors are willing to pay more for this company's shares. OppenheimerFunds Inc. boosted its stake in Exact Sciences Corporation by 66.8% in the first quarter. When we divide the last trade volume by the 3-month average volume, we found out a relative volume of 1.38. Blackrock Advisors Llc stated it has 0% of its portfolio in EXACT Sciences Corporation (NASDAQ:EXAS). $117,946 worth of EXACT Sciences Corporation (NASDAQ:EXAS) shares were sold by ARORA MANEESH. About 3.90 million shares traded or 74.89% up from the average. EXACT Sciences Corporation (NASDAQ:EXAS) has risen 458.24% since July 27, 2016 and is uptrending. It has outperformed by 441.54% the S&P500.

Since February 24, 2017, it had 0 buys, and 9 selling transactions for $1.67 million activity. On Monday, March 13 the insider Conroy Kevin T sold $255,168. COWARD D SCOTT sold $36,631 worth of stock. 8,668 shares were sold by LIDGARD GRAHAM PETER, worth $186,429 on Friday, February 24.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Altre relazioni OverNewsmagazine

Discuti questo articolo

SEGUI I NOSTRI GIORNALE